6657 — Energenesis Biomedical Co Income Statement
0.000.00%
Last trade - 00:00- TWD5.16bn
- TWD4.50bn
- TWD7.75m
Annual income statement for Energenesis Biomedical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.08 | 7.49 | 7.35 | 7.16 | 7.75 |
| Cost of Revenue | |||||
| Gross Profit | 4.83 | 5.36 | 5.17 | 5.23 | 5.69 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 141 | 130 | 279 | 269 | 263 |
| Operating Profit | -134 | -122 | -272 | -262 | -255 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -129 | -120 | -266 | -260 | -231 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -129 | -120 | -266 | -260 | -231 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -129 | -120 | -266 | -260 | -231 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -129 | -120 | -266 | -260 | -231 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.17 | -1.98 | -3.94 | -3.57 | -3.03 |
| Dividends per Share |